In CF, higher producing TGFβ polymorphisms have been linked to more severe lung disease; furthermore, higher levels of TGFβ in the BAL and plasma are associated with worse outcomes in children with CF [20–22]. This evidence concerns the gene TGFB1 and lung disorder.